Litcius/Paper detail

Bulleyaconitine A is a sensitive substrate and competitive inhibitor of CYP3A4: One of the possible explanations for clinical adverse reactions

Xiaocui Li, Xiaowen Ou, Jiadong Ni, Yihong Xu, Zuo Huilin, Yu Fu, Caihua Yang, Zhongxiang Zhao, Na Li, Hua Zhou, Rong Zhang, Zhongqiu Liu, Ling Fu, Lijun Zhu

2022Toxicology and Applied Pharmacology10 citationsDOI

Topics & Concepts

CYP3A4PharmacologyCYP3AChemistryCytochrome P450CYP1A2Non-competitive inhibitionEnzymeMicrosomeKetoconazoleCYP2B6Mechanism of actionDrug metabolismMetaboliteIn vitroBiochemistryBiologyMicrobiologyAntifungalPlant-based Medicinal ResearchPharmacogenetics and Drug MetabolismPharmacological Effects of Natural Compounds
Bulleyaconitine A is a sensitive substrate and competitive inhibitor of CYP3A4: One of the possible explanations for clinical adverse reactions | Litcius